Mid-Year Report

CLARK & WEINSTOCK for PHRMA

Period Mid-Year 2007 Filed Aug 6, 2007

Official filing
Firm
CLARK & WEINSTOCK
Client
PHRMA
Income
$120,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Doha/Cancun. Australia Free Trade Negotiations.

LobbyistCovered position, as disclosed
DAVID J BERTEAU N/A
KENT BONHAM N/A
ED KUTLER N/A
DIRKSEN LEHMAN N/A
JONATHAN SCHWANTES GENERAL COUNSEL, SENATE JUDICIARY CMTE (KOHL)
DEIRDRE STACH N/A
VIN WEBER N/A

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Health Issues HCR

Implementation of Medicare law--P.L. 108-173; all sections related to prescription drugs. S. 184, Safe Importation of Medical Products and Other Rx Therapies Act of 2004. S. 2307, Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004. S. 4, Medicare Modernization Act Implementation. H.R. 2900, Prescription Drug User Fee Act Reauthorization. S. 328, Pharmaceutical Market Access Act. H.R. 3162, SCHIP Reauthorization. H.R. 3161, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2008, sections related to FDA funding. S. 251, Pharmaceutical Market Access and Drug Safety Act of 2007, relating to reimportation.

LobbyistCovered position, as disclosed
DAVID J BERTEAU N/A
KENT BONHAM N/A
ED KUTLER N/A
DIRKSEN LEHMAN N/A
JONATHAN SCHWANTES GENERAL COUNSEL, SENATE JUDICIARY CMTE (KOHL)
DEIRDRE STACH N/A
VIN WEBER N/A

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: S. 328 (110th), S. 184 (110th), S. 4 (110th), H.R. 3162 (110th), H.R. 3161 (110th), S. 251 (110th), H.R. 2900 (110th), S. 2307 (110th)

Medicare/Medicaid MMM

S. 51, Generic Pharmaceutical Access and Choice for Consumers Act of 2003; sections relating to substitution of generic drugs for innovator products. S. 251, Pharmaceutical Market Access Act of 2003, relating to reimportation. Implementation of Medicare law -- P.L. 108-173; all sections related to prescription drugs. Deficit Reduction Act. H.R. 3161, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2008, sections related to FDA funding.

LobbyistCovered position, as disclosed
DAVID J BERTEAU N/A
KENT BONHAM N/A
ED KUTLER N/A
DIRKSEN LEHMAN N/A
JONATHAN SCHWANTES GENERAL COUNSEL, SENATE JUDICIARY CMTE (KOHL)
DEIRDRE STACH N/A
VIN WEBER N/A

Contacted: SENATE; Executive Office of the President (EOP); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 251 (110th), S. 51 (110th), H.R. 3161 (110th)

Medical/Disease Research/Clinical Labs MED

for innovator products. S. 251, Pharmaceutical Market Access Act of 2007, relating to reimportation. Implementation of Medicare law -- P.L. 108-173; all sections related to prescription drugs. H.R. 3161, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2008, sections related to FDA funding. S. 51, Preserve Access to Affordable Generics Act; sections relating to substitution of generic drugs

LobbyistCovered position, as disclosed
DAVID J BERTEAU N/A
KENT BONHAM N/A
ED KUTLER N/A
DIRKSEN LEHMAN N/A
JONATHAN SCHWANTES GENERAL COUNSEL, SENATE JUDICIARY CMTE (KOHL)
DEIRDRE STACH N/A
VIN WEBER N/A

Contacted: SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 251 (110th), H.R. 3161 (110th), S. 51 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.